Literature DB >> 7711722

Localization to chromosome 7q36.1 of the human XRCC2 gene, determining sensitivity to DNA-damaging agents.

J Thacker1, C E Tambini, P J Simpson, L C Tsui, S W Scherer.   

Abstract

The identification of genes controlling cellular response to DNA damage is of considerable importance, and cell lines showing hypersensitivity to DNA-damaging agents can be used as vehicles to map and clone these genes. In this study the hamster cell line irs1, showing hypersensitivity to a number of different DNA-damaging agents, was fused to normal human cells to complement the defect. The resultant hybrids were analysed by Alu-PCR, chromosome painting, and with DNA markers to map the complementing gene (named XRCC2) to a specific chromosomal region. These hybrids showed correction of sensitivity to both X-rays and to mitomycin-C, and contained human chromosome 7, often as their only human component. Hybrids showing unstable retention of human chromosomes were sub-cloned to show that loss of chromosome 7 and loss of resistance to mitomycin-C occurred concordantly. Two separate hybrids were found to have a smaller piece of chromosome 7, and specific DNA probes and microsatellite markers defined this as a contiguous region at 7q35-36. Hybrid irradiation-fusion methods were used to further reduce the size of the complementing genomic region and to localize the gene to an approximately 3-5 Mb region at 7q36.1.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7711722     DOI: 10.1093/hmg/4.1.113

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  11 in total

1.  Suppression of retroviral infection by the RAD52 DNA repair protein.

Authors:  Alan Lau; Roland Kanaar; Stephen P Jackson; Mark J O'Connor
Journal:  EMBO J       Date:  2004-08-05       Impact factor: 11.598

2.  Isolation of novel human and mouse genes of the recA/RAD51 recombination-repair gene family.

Authors:  R Cartwright; A M Dunn; P J Simpson; C E Tambini; J Thacker
Journal:  Nucleic Acids Res       Date:  1998-04-01       Impact factor: 16.971

3.  The XRCC2 DNA repair gene from human and mouse encodes a novel member of the recA/RAD51 family.

Authors:  R Cartwright; C E Tambini; P J Simpson; J Thacker
Journal:  Nucleic Acids Res       Date:  1998-07-01       Impact factor: 16.971

4.  Region and amino acid residues required for Rad51C binding in the human Xrcc3 protein.

Authors:  Hitoshi Kurumizaka; Rima Enomoto; Maki Nakada; Keiko Eda; Shigeyuki Yokoyama; Takehiko Shibata
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

5.  Homologous recombination is necessary for normal lymphocyte development.

Authors:  Lura B Caddle; Muneer G Hasham; William H Schott; Bobbi-Jo Shirley; Kevin D Mills
Journal:  Mol Cell Biol       Date:  2008-01-22       Impact factor: 4.272

6.  Widespread genomic breaks generated by activation-induced cytidine deaminase are prevented by homologous recombination.

Authors:  Muneer G Hasham; Nina M Donghia; Eliot Coffey; Jane Maynard; Kathy J Snow; Jacquelyn Ames; Robert Y Wilpan; Yishu He; Benjamin L King; Kevin D Mills
Journal:  Nat Immunol       Date:  2010-07-25       Impact factor: 25.606

7.  XRCC2 rs3218536 polymorphism decreases the sensitivity of colorectal cancer cells to poly(ADP-ribose) polymerase 1 inhibitor.

Authors:  Kaiwu Xu; Xinming Song; Zhihui Chen; Changjiang Qin; Yulong He
Journal:  Oncol Lett       Date:  2014-06-11       Impact factor: 2.967

8.  XRCC2 promotes colorectal cancer cell growth, regulates cell cycle progression, and apoptosis.

Authors:  Kaiwu Xu; Xinming Song; Zhihui Chen; Changjiang Qin; Yulong He; Wenhua Zhan
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

9.  Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).

Authors:  Sudha K Iyengar; John R Sedor; Barry I Freedman; W H Linda Kao; Matthias Kretzler; Benjamin J Keller; Hanna E Abboud; Sharon G Adler; Lyle G Best; Donald W Bowden; Allison Burlock; Yii-Der Ida Chen; Shelley A Cole; Mary E Comeau; Jeffrey M Curtis; Jasmin Divers; Christiane Drechsler; Ravi Duggirala; Robert C Elston; Xiuqing Guo; Huateng Huang; Michael Marcus Hoffmann; Barbara V Howard; Eli Ipp; Paul L Kimmel; Michael J Klag; William C Knowler; Orly F Kohn; Tennille S Leak; David J Leehey; Man Li; Alka Malhotra; Winfried März; Viji Nair; Robert G Nelson; Susanne B Nicholas; Stephen J O'Brien; Madeleine V Pahl; Rulan S Parekh; Marcus G Pezzolesi; Rebekah S Rasooly; Charles N Rotimi; Jerome I Rotter; Jeffrey R Schelling; Michael F Seldin; Vallabh O Shah; Adam M Smiles; Michael W Smith; Kent D Taylor; Farook Thameem; Denyse P Thornley-Brown; Barbara J Truitt; Christoph Wanner; E Jennifer Weil; Cheryl A Winkler; Philip G Zager; Robert P Igo; Robert L Hanson; Carl D Langefeld
Journal:  PLoS Genet       Date:  2015-08-25       Impact factor: 5.917

10.  miR-7 inhibits colorectal cancer cell proliferation and induces apoptosis by targeting XRCC2.

Authors:  Kaiwu Xu; Zhihui Chen; Changjiang Qin; Xinming Song
Journal:  Onco Targets Ther       Date:  2014-02-20       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.